Zhang Zhiqian, Mena Elijah L, Timms Richard T, Koren Itay, Elledge Stephen J
Department of Genetics, Harvard Medical School, Division of Genetics, Brigham and Women's Hospital, Howard Hughes Medical Institute, Boston, MA, USA.
Cambridge Institute of Therapeutic Immunology and Infectious Disease, Department of Medicine, University of Cambridge, Cambridge, UK.
Nat Rev Mol Cell Biol. 2025 Jul 14. doi: 10.1038/s41580-025-00870-z.
Degrons are pivotal components of the ubiquitin-proteasome system, serving as the recognition determinants through which E3 ubiquitin ligases identify their substrates. Degrons have central roles in both protein quality control and intracellular signalling pathways, and mutations that dysregulate degron activity are associated with a wide range of diseases, including cancer, immunological disorders and neurodegeneration. The number of well-defined degrons remains sparse relative to the ~600 E3 ubiquitin ligases encoded in the human genome. Recent advances in high-throughput degron discovery technologies have accelerated progress in this area, expanding the number of N- and C-terminal degrons, internal degrons and ubiquitin-independent degrons defined experimentally at high resolution. In this Review, we discuss the latest insights into the molecular mechanisms through which degrons act, their functional importance and their relevance in human disease, and consider how bifunctional molecules harness degrons to enable targeted protein degradation for therapeutic benefit.
降解决定子是泛素-蛋白酶体系统的关键组成部分,作为识别决定因素,E3泛素连接酶通过它来识别其底物。降解决定子在蛋白质质量控制和细胞内信号通路中都起着核心作用,而失调降解决定子活性的突变与多种疾病相关,包括癌症、免疫紊乱和神经退行性变。相对于人类基因组中编码的约600种E3泛素连接酶,明确的降解决定子数量仍然稀少。高通量降解决定子发现技术的最新进展加速了该领域的进展,扩大了在高分辨率下通过实验确定的N端和C端降解决定子、内部降解决定子和不依赖泛素的降解决定子的数量。在本综述中,我们讨论了关于降解决定子作用的分子机制、它们的功能重要性及其在人类疾病中的相关性的最新见解,并考虑双功能分子如何利用降解决定子实现靶向蛋白质降解以获得治疗益处。